[HTML][HTML] Systems biology analysis of mitogen activated protein kinase inhibitor resistance in malignant melanoma
H Zecena, D Tveit, Z Wang, A Farhat, P Panchal… - BMC systems …, 2018 - Springer
Background Kinase inhibition in the mitogen activated protein kinase (MAPK) pathway is a
standard therapy for cancer patients with activating BRAF mutations. However, the anti-…
standard therapy for cancer patients with activating BRAF mutations. However, the anti-…
Increased glutaminolytic flux and activation of mitochondrial metabolism by BCL2 hyperactivity in lymphoma
B-cell lymphoma 2 (BCL2) is an important apoptosis regulator during developmental and
pathological states, and its overexpression is a key feature of several malignancies. Genomic …
pathological states, and its overexpression is a key feature of several malignancies. Genomic …
From Bench to Community: Addressing Health Disparities by Investigating Host Metabolic Benefits of Red Raspberry Polyphenols and Understanding the …
AM Toney - 2021 - search.proquest.com
… I want to thank my best friend, Helma Zecena, who has supported me and watched me grow
since we were fifteen. I am so thankful to have you in my life. I also want to thank the heart of …
since we were fifteen. I am so thankful to have you in my life. I also want to thank the heart of …